P3 Health Partners (NASDAQ:PIII) Price Target Lowered to $0.25 at TD Cowen

P3 Health Partners (NASDAQ:PIII) had its price target reduced by research analysts at TD Cowen from $0.90 to $0.25 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen’s price target points to a potential upside of 13.84% from the stock’s previous close.

P3 Health Partners Price Performance

PIII opened at $0.22 on Wednesday. The business has a fifty day moving average of $0.37 and a 200 day moving average of $0.50. The stock has a market cap of $78.56 million, a P/E ratio of -0.26 and a beta of 1.15. P3 Health Partners has a 52-week low of $0.19 and a 52-week high of $1.78. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.11.

Insider Activity

In other P3 Health Partners news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of P3 Health Partners stock in a transaction on Friday, September 6th. The shares were bought at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the completion of the transaction, the insider now directly owns 76,785,438 shares of the company’s stock, valued at $37,624,864.62. This trade represents a 0.10 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders acquired 400,000 shares of company stock worth $205,600 over the last three months. 17.86% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Armistice Capital LLC acquired a new position in P3 Health Partners during the second quarter worth approximately $3,557,000. Renaissance Technologies LLC raised its position in P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after acquiring an additional 73,000 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after purchasing an additional 550,925 shares during the period. Emfo LLC increased its stake in P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares in the last quarter. Finally, Sanders Morris Harris LLC increased its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after acquiring an additional 20,000 shares in the last quarter. Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.